SEC 13F Intelligence

Trails Edge Capital Partners, LP / DSGN

Trails Edge Capital Partners, LP’s Design Therapeutics Inc Position

Does Trails Edge Capital Partners, LP own Design Therapeutics Inc (DSGN)? Yes852.0K shares worth $9M (+2.08% of its 13F portfolio) as of Q1 2026.

Position Value
$9M
Q1 2026
Shares
852.0K
% of Portfolio
+2.08%
Quarters Held
1
currently held

Position History DSGN

Reported value by quarter
Q1 ’26: $9MQ1 ’26filingsflow.com
QuarterSharesValue% of Portfolio
Q1 2026852.0K$9M+2.08%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Trails Edge Capital Partners, LP’s full portfolio or all institutional holders of DSGN.